[go: up one dir, main page]

ES2100689T3 - Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2. - Google Patents

Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.

Info

Publication number
ES2100689T3
ES2100689T3 ES94904685T ES94904685T ES2100689T3 ES 2100689 T3 ES2100689 T3 ES 2100689T3 ES 94904685 T ES94904685 T ES 94904685T ES 94904685 T ES94904685 T ES 94904685T ES 2100689 T3 ES2100689 T3 ES 2100689T3
Authority
ES
Spain
Prior art keywords
receptors
synergizing
association
antagonist effect
product equipped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94904685T
Other languages
English (en)
Inventor
Claude Garret
Francois Montier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2100689T3 publication Critical patent/ES2100689T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Soil Working Implements (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

ASOCIACION SINERGIZANTE CARACTERIZADAS EN QUE ESTAN CONSTITUIDAS POR AL MENOS UN PRODUCTO DOTADO CON UNA ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES NK1 Y POR AL MENOS UN PRODUCTO DOTADO CON UNA ACTIVIDAD DE LOS RECEPTORES NK2. ESTAS ASOCIACIONES SON INTERESANTES EN EL TRATAMIENTO DE LAS AFECCIONES EN LAS QUE INTERVIENEN LA SUSTANCIA P Y/O LA NEUROQUININA A.
ES94904685T 1993-01-19 1994-01-18 Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2. Expired - Lifetime ES2100689T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300451A FR2700472B1 (fr) 1993-01-19 1993-01-19 Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2.

Publications (1)

Publication Number Publication Date
ES2100689T3 true ES2100689T3 (es) 1997-06-16

Family

ID=9443143

Family Applications (2)

Application Number Title Priority Date Filing Date
ES94904685T Expired - Lifetime ES2100689T3 (es) 1993-01-19 1994-01-18 Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.
ES09400092A Expired - Fee Related ES2091712B1 (es) 1993-01-19 1994-01-18 Asociaciones sinergizantes que tienen un efecto antagonista de los receptores nk1 y nk2.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES09400092A Expired - Fee Related ES2091712B1 (es) 1993-01-19 1994-01-18 Asociaciones sinergizantes que tienen un efecto antagonista de los receptores nk1 y nk2.

Country Status (25)

Country Link
US (1) US6177450B1 (es)
EP (1) EP0680323B1 (es)
JP (1) JP4341783B2 (es)
KR (1) KR100342152B1 (es)
AT (1) ATE150972T1 (es)
AU (1) AU682166B2 (es)
BE (1) BE1006705A3 (es)
CA (1) CA2152401C (es)
CH (1) CH687503A5 (es)
DE (1) DE69402411T2 (es)
DK (1) DK0680323T3 (es)
ES (2) ES2100689T3 (es)
FR (1) FR2700472B1 (es)
GB (1) GB2274777B (es)
GR (1) GR3023021T3 (es)
IE (1) IE940035A1 (es)
IL (1) IL108356A (es)
IT (1) IT1269185B (es)
LU (1) LU88442A1 (es)
NO (1) NO315077B1 (es)
NZ (1) NZ259728A (es)
PT (1) PT101444A (es)
TW (1) TW381021B (es)
WO (1) WO1994016697A1 (es)
ZA (1) ZA94333B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287404A (en) * 1994-03-15 1995-09-20 Pfizer Antiinflammatory and analgesic compositions
CA2205016A1 (en) * 1994-11-10 1996-05-23 Hans-Jurgen Ernst Hess Nk-1 receptor antagonists for the treatment of eye disorders
US5688960A (en) * 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
US5696267A (en) * 1995-05-02 1997-12-09 Schering Corporation Substituted oximes, hydrazones and olefins as neurokinin antagonists
FR2738245B1 (fr) * 1995-08-28 1997-11-21 Sanofi Sa Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
US5691362A (en) * 1996-06-05 1997-11-25 Schering-Plough Corporation Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
US5789422A (en) * 1996-10-28 1998-08-04 Schering Corporation Substituted arylalkylamines as neurokinin antagonists
JP2001507678A (ja) * 1996-12-02 2001-06-12 メルク シヤープ エンド ドーム リミテツド 運動障害の治療のためのｎｋ−１受容体拮抗薬の使用
US6156749A (en) * 1997-12-01 2000-12-05 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
US20100189797A1 (en) 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
AU2004283038B9 (en) * 2003-10-27 2008-04-24 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164372A (en) 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
FI97540C (fi) 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
GB8929070D0 (en) 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
US5232929A (en) 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2678267B1 (fr) 1991-06-25 1994-02-04 Elf Sanofi Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB9023116D0 (en) 1990-10-24 1990-12-05 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
EP0499313B1 (en) 1991-02-11 1997-06-11 MERCK SHARP & DOHME LTD. Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
JPH06507402A (ja) 1991-03-20 1994-08-25 ワーナー−ランバート・コンパニー 治療活性を有するα−置換ポリペプチド
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2676053B1 (fr) 1991-05-03 1993-08-27 Sanofi Elf Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
BR9206161A (pt) 1991-06-20 1995-10-31 Pfizer Derivados fluoroalcoxibenzilamino de heterociclos contendo nitrogénio
TW202432B (es) 1991-06-21 1993-03-21 Pfizer
US5288730A (en) 1991-06-24 1994-02-22 Merck Sharp & Dohme Limited Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001169A2 (en) 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
EP0536817A1 (en) 1991-07-05 1993-04-14 MERCK SHARP & DOHME LTD. Azabicyclic compounds as tachykinin antagonists
DE69208088T2 (de) 1991-07-05 1996-11-14 Merck Sharp & Dohme Aromatische verbindungen, diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische anwendung
WO1993001159A1 (en) 1991-07-10 1993-01-21 Merck Sharp & Dohme Limited Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
JPH06509090A (ja) 1991-07-10 1994-10-13 メルク　シヤープ　エンド　ドーム　リミテツド 芳香族化合物、それらを含む組成物、及び治療におけるそれらの使用
MY110227A (en) 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
WO1993004040A1 (en) 1991-08-20 1993-03-04 Merck Sharp & Dohme Limited Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
PT533280E (pt) 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina
CZ59394A3 (en) 1991-09-26 1994-11-16 Pfizer Condensed tricyclic heterocycles containing nitrogen as antagonists of p substance receptor, process of their preparation, intermediates, pharmaceutical preparations in which they are comprised and use
WO1993009116A1 (fr) 1991-11-07 1993-05-13 Yoshitomi Pharmaceutical Industries, Ltd. Compose a base de quinuclidine et utilisation dudit compose en medecine
DK0613458T3 (da) 1991-11-12 1998-02-09 Pfizer Acykliske ethylendiaminderivater som substans P receptorantagonister
CA2083891A1 (en) 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
GB9201179D0 (en) 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
US5328927A (en) 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
JP2656702B2 (ja) 1992-03-23 1997-09-24 ファイザー製薬株式会社 ペプチド性キヌクリジン
FR2689888B1 (fr) 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
CA2133077A1 (en) 1992-04-15 1993-10-28 Raymond Baker Azacyclic compounds
CA2134964C (en) 1992-05-18 1997-12-30 Manoj C. Desai Bridged aza-bicyclic derivatives as substance p antagonists

Also Published As

Publication number Publication date
JP4341783B2 (ja) 2009-10-07
NO952828D0 (no) 1995-07-17
EP0680323B1 (fr) 1997-04-02
GB2274777B (en) 1996-10-02
DE69402411T2 (de) 1997-10-30
CA2152401A1 (fr) 1994-08-04
GR3023021T3 (en) 1997-07-30
US6177450B1 (en) 2001-01-23
AU5862794A (en) 1994-08-15
JPH08505637A (ja) 1996-06-18
KR960700056A (ko) 1996-01-19
ZA94333B (en) 1994-09-02
ITMI940039A0 (it) 1994-01-14
ES2091712A1 (es) 1996-11-01
DK0680323T3 (da) 1997-10-20
WO1994016697A1 (fr) 1994-08-04
IL108356A0 (en) 1994-04-12
DE69402411D1 (de) 1997-05-07
ATE150972T1 (de) 1997-04-15
CA2152401C (fr) 2008-08-26
KR100342152B1 (ko) 2003-02-26
TW381021B (en) 2000-02-01
CH687503A5 (fr) 1996-12-31
GB9400691D0 (en) 1994-03-09
BE1006705A3 (fr) 1994-11-22
NO952828L (no) 1995-07-17
GB2274777A (en) 1994-08-10
IT1269185B (it) 1997-03-21
AU682166B2 (en) 1997-09-25
NZ259728A (en) 1996-05-28
FR2700472A1 (fr) 1994-07-22
PT101444A (pt) 1994-10-31
ITMI940039A1 (it) 1995-07-14
ES2091712B1 (es) 1997-08-01
LU88442A1 (fr) 1994-10-03
IL108356A (en) 1998-09-24
IE940035A1 (en) 1994-07-27
NO315077B1 (no) 2003-07-07
FR2700472B1 (fr) 1995-02-17
EP0680323A1 (fr) 1995-11-08

Similar Documents

Publication Publication Date Title
ES2100689T3 (es) Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.
ES2151921T3 (es) Analogo de dolastatina.
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
DE68925801D1 (de) Biozide Zusammensetzungen
ES2081870T3 (es) Composiciones polipropilenicas plasto-elasticas.
UY24006A1 (es) Derivado del 2-(2-amino -1,6-dihidro-6-oxo-purin-9-il)metoxil-1,3-propanodiol.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ES2167544T3 (es) Dioxidos de benzotiazina como antagonistas de la endotelina.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
MX9302378A (es) Antagonistas de serotonina.
MX9204730A (es) Novedosas ureas 4-oxociclicas utiles como agentes antiarritmicos y antifibralatorios.
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
ES2048793T3 (es) Antibioticos antifungicos.
ES2183923T3 (es) Derivados de cromona.
MX9300529A (es) Pesticidas.
ES2084771T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
GT199500039AA (es) Compuestos ariltios
ES2135535T3 (es) Derivados tiazolotriazol y tiazolodiazol con actividad fungicida.
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
ES2181722T3 (es) Marcfortinas sustituidas en la posicion 14 y derivados utiles como agentes antiparasitarios.
FR2704422B3 (fr) Implant oculaire.
ES2061802T3 (es) Derivados de 19-fluor- o ciano-21-hidroxiprogesterona utiles como inhibidores de 19-hidroxilasa.
FR2686244B3 (fr) Ligament artificiel.
TR27235A (tr) Sinerjistik ensektisit bilesimleri.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680323

Country of ref document: ES